Cardiac AI: The Billion-Dollar ROI for Value-Based Care
Health systems are getting squeezed, so when it comes to AI, the pressure is on to show real cost savings. Investors are done with the…
Health systems are getting squeezed, so when it comes to AI, the pressure is on to show real cost savings. Investors are done with the…
The Centers for Medicare & Medicaid Services (CMS) have, with the release of the Interoperability and Prior Authorization Final Rule (CMS-0057-F), irrevocably reshaped the operational…
Transitioning oncology to value-based care (VBC) models presents a formidable challenge, primarily due to the high costs associated with novel therapies and the inherent complexity…
Digital musculoskeletal (MSK) programs have proliferated, promising significant relief for a major category of employer health spend. Yet, the financial claims associated with these solutions…
The field of value-based care is rapidly evolving, and with it, the scrutiny applied to the economic claims of digital health platforms. Short-term pilot programs,…
The promise of AI in healthcare is vast, yet its true impact on value-based care (VBC) hinges not on ephemeral pilot results, but on demonstrable,…
The promise of artificial intelligence in healthcare is vast, offering pathways to improved outcomes and significant cost reductions. However, for employers and health plan executives…
Self-insured employers and their human resources leaders face a critical juncture in managing healthcare costs: the promise of artificial intelligence (AI) to deliver efficiencies and…
The recent implosion of Pear Therapeutics, once a darling of the digital therapeutics (DTx) space, serves as a stark, cautionary tale for investors and health…
The promise of artificial intelligence in healthcare is undeniable, offering pathways to improved diagnostics, personalized treatment, and operational efficiencies. Yet, for AI to truly transform…